Trending...
- SPJ's Green Eyeshade Awards Journalism Competition, Celebrating 75 Years, Announces 2025 Honors
- Santa Monica Businesses Push Back on Bus Stop Relocation That Threatens Access and Safety
- GreenPal Empowers Lawn Care Pros Leveraging AI, Surpasses 5 Million Transactions
MCI's total commitment to male contraception now exceeds $3M USD since 2017
DURHAM, N.C. - ncarol.com -- Male Contraceptive Initiative (MCI), a private non-profit foundation, announced four grants, including a grant to Eppin Pharma Inc to support research and development of a male contraceptive, raising MCI's total commitment to male contraception to over $3M USD since 2017.
Eppin Pharma will receive $300,000 to aid in their work developing a novel form of male contraception. Eppin Pharma's product, EP055, is a hormone-free method of contraception that is quickly moving to first-in-human studies. EP055 inhibits sperm motility that is crucial for fertility. The drug is intended to be administered as a pill to men on a daily or on-demand basis, providing protection from pregnancy.
With over $3 million invested in male contraceptive product development, MCI seeks to push male contraceptive research projects towards commercialization. There are a variety of male contraceptive research projects in the drug development pipeline; from early stage screening of drugs to studies that pave the way for early clinical trials, and consistent with their mission, MCI focuses their funding on promising projects within this pipeline like Eppin Pharma's EP055. MCI's mission is to facilitate research and development of male contraceptives for people around the world, and to build awareness among researchers, donors and the general public about the demand for and status of novel male contraceptive methods.
More on ncarol.com
Through its funding efforts, MCI has championed this mission in manifold ways: investing in promising product development through this and other rounds of funding, supporting students and young professionals through fellowships and travel grants, and consistently advocating with the public and media for an increased method mix that includes male contraception.
"More and more men are expressing the desire to participate in contraception with their partners. We are confident that the time is right to emphatically get behind the talent and energy in the field in order to achieve a real vision for a shared contraceptive future," said MCI Executive Director Heather Vahdat.
Dr. Michael O'Rand, CEO and Co-Founder of Eppin added – "We are grateful for the support that MCI has given us and hopeful that this investment in our technology will advance the field of male non-hormonal contraception."
https://www.malecontraceptive.org/
Eppin Pharma will receive $300,000 to aid in their work developing a novel form of male contraception. Eppin Pharma's product, EP055, is a hormone-free method of contraception that is quickly moving to first-in-human studies. EP055 inhibits sperm motility that is crucial for fertility. The drug is intended to be administered as a pill to men on a daily or on-demand basis, providing protection from pregnancy.
With over $3 million invested in male contraceptive product development, MCI seeks to push male contraceptive research projects towards commercialization. There are a variety of male contraceptive research projects in the drug development pipeline; from early stage screening of drugs to studies that pave the way for early clinical trials, and consistent with their mission, MCI focuses their funding on promising projects within this pipeline like Eppin Pharma's EP055. MCI's mission is to facilitate research and development of male contraceptives for people around the world, and to build awareness among researchers, donors and the general public about the demand for and status of novel male contraceptive methods.
More on ncarol.com
- Rent Like A Champion Acquires CollegeWeekends
- First Flight Society Celebrates National Aviation Day 2025 on Tuesday, August 19th
- Sumter Landing Dental Care Launches Summer Special on Full Mouth Reconstruction
- Seligson Law Launches New Website to Support Cannabis Businesses in California and New York
- Free Marketing Book Saves Brands from Being Ignored
Through its funding efforts, MCI has championed this mission in manifold ways: investing in promising product development through this and other rounds of funding, supporting students and young professionals through fellowships and travel grants, and consistently advocating with the public and media for an increased method mix that includes male contraception.
"More and more men are expressing the desire to participate in contraception with their partners. We are confident that the time is right to emphatically get behind the talent and energy in the field in order to achieve a real vision for a shared contraceptive future," said MCI Executive Director Heather Vahdat.
Dr. Michael O'Rand, CEO and Co-Founder of Eppin added – "We are grateful for the support that MCI has given us and hopeful that this investment in our technology will advance the field of male non-hormonal contraception."
https://www.malecontraceptive.org/
Source: Male Contraceptive Initiative
Filed Under: Health
0 Comments
Latest on ncarol.com
- Yasmine Roulleau named Managing Director in Vancouver, Canada
- Chasing Elizabeth Taylor — The Dazzling True Story Behind the Queen of Diamonds Now Available in Limited-Edition Hardcover
- A Dream in Blue: Honoring Tony Treadwell's Lifelong Love of Football
- $53 Million Company Valuation Investment with Majority Acquisition Option, Plus New Stock CUSIP Supporting Brand Transition of Fan Engagement Company
- $14M Deal with Famed David Lloyd for Sports, Entertainment & Gaming, AI Powered Fan Engagement Company; New Stock CUSIP; Creating Shareholder Value
- Disposable Vape Ban Spurs Hayati Innovation
- Prolific Hollywood "Unknown Actor" Leads 11 Day SoCal, Hands-On, Performer Employment Securing Residency that Shows Others How to Get More Work
- Dr. Harmon Completes Prestigious Zygomatic Implant Residency in Brazil
- Agreement to Deliver Thin-Film Solar Technology to Space Solar Array Provider, NASA Collaborative Agreement for Orbital Applications in Power Beaming
- Iterators LLC Honored with IST82 State Award for Accessibility in Massachusetts
- Josh & Heidi Share Upcoming "Spreading the Good BUZZ" Podcast Guests, Select Top Five Elopement Locations as Their Instagram Presence Grows Globally
- Opteamix Launches StackRewrite.AI to Transform Enterprise Legacy Modernization
- "The Pornified Generation": Dr. Chris Samuels Exposes the Toxic Alliance Between Bro Culture and Pornography That's Rewiring a Generation
- Women Gather for "Glow Up Within: A Summer Journey to Self-Nourishment"
- The Modern Insurance Store Expands Medicare Help Services for Seniors in Cincinnati
- Ironside HR Named Fastest-Growing Staffing Firm for Second Year
- Inframark Continues to Build Its Community Management Capabilities and Multi-Disciplinary Presence in Arizona
- ICAST 2025: The Crystal-Clear Revolution Begins at Booth #3233
- Brindle Pet Supplies Now Carries Badlands Ranch Dog Food in Canada
- Duke Energy announces dividend payments to shareholders